Mandatory labeling requirements and over-the-counter cough and cold medication use in early childhood

被引：0
|
作者：
Julie Degroot
Laura N. Anderson
Yang Chen
Catherine S. Birken
Patricia C. Parkin
Sarah Carsley
Marina Khovratovich
Muhammad Mamdani
Jonathon L. Maguire
机构：
[1] University of Toronto,The Applied Health Research Centre of the Li Ka Shing Knowledge Institute, St. Michael’s Hospital
[2] The Hospital for Sick Children,Pediatric Outcomes Research Team (PORT), Division of Pediatric Medicine, Department of Pediatrics, University of Toronto
[3] University of Toronto,Institute for Health Policy, Management and Evaluation
[4] Department of Pediatrics,undefined
[5] St. Michael’s Hospital,undefined
来源：
Canadian Journal of Public Health | 2015年 / 106卷
关键词：
Nonprescription drugs; child; preschool; drug legislation; time series analysis; médicaments en vente libre; enfant d’âge préscolaire; législation pharmaceutique; analyse des séries chronologiques;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
OBJECTIVES: Due to rare but severe adverse events, Health Canada in October 2009 required manufacturers to relabel over-the-counter (OTC) cough and cold medication (CCM) to state that the products should not be used in children <6 years of age. The main objective of this study was to determine whether this labeling standard decreased OTC CCM use among young children with a recent cough, cold or flu.
引用
收藏
页码：e477 / e482
相关论文
共 50 条
12345